PTC Therapeutics Shareholder Sues In Del. Over Director Pay
A stockholder of biotechnology company PTC Therapeutics has challenged in Delaware's Court of Chancery allegedly "lavish" nonemployee director compensation awards that, in recent years, exceeded that of both peer group and...To view the full article, register now.
Already a subscriber? Click here to view full article